StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Available-for-sale marketable securities, current by Quarter

Available-for-sale (AFS) marketable securities, current — Fair value ($M) ($M)

QuarterlyAnnual

Moderna Available-for-sale marketable securities, current: $3,415M in Q2 2026, down 11.3% from a year earlier.

Latest, Q2 2026
3,415
Period ended Jun 30, 2026
Change on a year earlier
-11.3%
3,852 in Q2 2025
History
31 quarters
Since Q4 2018
Sources
30
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Note 5 (Cash, Cash Equivalents and Marketable Securities).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAvailable-for-sale (AFS) marketable securities, current — Fair value ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,415-11.3%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 20263,297-24.2%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 20253,204-37.2%Form 10-Q (filed 2026-07-31) ↗
Q3 2025Sep 30, 20253,372-35.4%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20253,852-35.9%Form 10-Q (filed 2025-08-01) ↗
Q1 2025Mar 31, 20254,352-32.8%Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 20245,098-10.5%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 20245,223+12.5%Form 10-Q (filed 2024-11-07) ↗
Q2 2024Jun 30, 20246,010+29.0%Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 20246,472+18.1%Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 20235,697-14.9%Form 10-K (filed 2025-02-21) ↗
Q3 2023Sep 30, 20234,641-12.8%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20234,658-7.3%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 20235,482+8.2%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 20226,697+72.6%Form 10-K (filed 2024-02-23) ↗
Q3 2022Sep 30, 20225,321+58.6%Form 10-Q (filed 2022-11-03) ↗

Breakdown

What makes up available-for-sale marketable securities, current

Cite this data

StockData. (2026). Moderna Available-for-sale marketable securities, current ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/afs-cur-fv

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.